Thyrocare Technologies
Thyrocare Technologies Performance
Day Range
- Low 554.95
- High 574.95
52 Week Range
- Low 415.4
- High 768.25
- Open Price556.6
- Previous Close553.8
- Volume70186
Start SIP in Thyrocare Technologies
Start SIPThyrocare Technologies Investment Rating
-
Master Rating:
-
Thyrocare Technologies has an operating revenue of Rs. 533.77 Cr. on a trailing 12-month basis. An annual revenue de-growth of -13% needs improvement, Pre-tax margin of 17% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 9% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 124 | 125 | 117 | 125 | 119 | 123 |
Operating Expenses Qtr Cr | 90 | 102 | 91 | 96 | 85 | 87 |
Operating Profit Qtr Cr | 33 | 23 | 26 | 30 | 34 | 37 |
Depreciation Qtr Cr | 9 | 9 | 9 | 8 | 8 | 9 |
Interest Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
Tax Qtr Cr | 8 | 5 | 5 | 8 | 6 | 9 |
Net Profit Qtr Cr | 17 | 10 | 13 | 14 | 20 | 20 |
Thyrocare Technologies Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹558.32
- 50 Day
- ₹551.05
- 100 Day
- ₹538.74
- 200 Day
- ₹552.07
- 20 Day
- ₹557.89
- 50 Day
- ₹560.72
- 100 Day
- ₹526.93
- 200 Day
- ₹518.91
Thyrocare Technologies Resistance and Support
Resistance | |
---|---|
First Resistance | ₹577.19 |
Second Resistance | ₹586.07 |
Third Resistance | ₹597.19 |
RSI | 55.48 |
MFI | 61.99 |
MACD Single Line | 2.53 |
MACD | 2.41 |
Support | |
---|---|
First Resistance | ₹557.19 |
Second Resistance | ₹546.07 |
Third Resistance | ₹537.19 |
Thyrocare Technologies Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 78,445 | 2,616,141 | 33.35 |
Week | 35,339 | 1,504,381 | 42.57 |
1 Month | 83,828 | 4,319,645 | 51.53 |
6 Month | 184,346 | 9,152,766 | 49.65 |
Thyrocare Technologies Result Highlights
Thyrocare Technologies Synopsis
NSE-Medical-Services
Thyrocare Tech. is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 486.46 Cr. and Equity Capital is Rs. 52.93 Cr. for the Year ended 31/03/2023. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.Market Cap | 3,008 |
Sales | 491 |
Shares in Float | 1.53 |
No of funds | 47 |
Yield | 3.17 |
Book Value | 5.77 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | |
Alpha | -0.09 |
Beta | 0.52 |
Thyrocare Technologies
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 71.14% | 71.14% | 71.14% | 71.14% |
Mutual Funds | 12.04% | 7.03% | 7.3% | 6.81% |
Insurance Companies | 1.08% | 1.08% | 1.08% | 1.85% |
Foreign Portfolio Investors | 3.44% | 9.99% | 10.13% | 10.42% |
Financial Institutions/ Banks | ||||
Individual Investors | 9.42% | 8.38% | 8.07% | 7.28% |
Others | 2.88% | 2.38% | 2.28% | 2.5% |
Thyrocare Technologies Management
Name | Designation |
---|---|
Mr. Rahul Guha | Managing Director & CEO |
Mr. Dharmil Sheth | Non Executive Director |
Mr. Hardik Dedhia | Non Executive Director |
Mr. Dhaval Shah | Non Executive Director |
Mr. Gopalkrishna Shivram Hegde | Independent Director |
Dr. Indumati Gopinathan | Independent Director |
Dr. Neetin S Desai | Independent Director |
Thyrocare Technologies Forecast
Price Estimates
Thyrocare Technologies Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-01 | Quarterly Results | |
2023-05-23 | Audited Results | |
2023-04-07 | Interim Dividend | |
2023-02-03 | Quarterly Results | |
2022-11-11 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-04-20 | INTERIM | Rs.18.00 per share(180%)Interim Dividend |
2022-05-12 | FINAL | Rs.15.00 per share(150%)Interim Dividend |
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 493
- 5.5
- NTPC
- 246
- 3.6
- Hero Motocorp
- 3057
- 2.9
- Dr Reddys Labs
- 5587
- 2.9
- Divis Lab.
- 3765
- 2.7
- Company Name
- CMP
- Chg(%)
- Adani Enterp.
- 2414
- -2.5
- LTIMindtree
- 5210
- -1.0
- HCL Technologies
- 1235
- -0.6
- Tech Mahindra
- 1223
- -0.5
- Power Grid Corpn
- 200
- -0.5
Thyrocare Technologies FAQs
What is Share Price of Thyrocare Technologies ?
Thyrocare Technologies share price is ₹568 As on 30 September, 2023 | 18:37
What is the Market Cap of Thyrocare Technologies ?
The Market Cap of Thyrocare Technologies is ₹3008 Cr As on 30 September, 2023 | 18:37
What is the P/E ratio of Thyrocare Technologies ?
The P/E ratio of Thyrocare Technologies is 50.1 As on 30 September, 2023 | 18:37
What is the PB ratio of Thyrocare Technologies ?
The PB ratio of Thyrocare Technologies is 5.6 As on 30 September, 2023 | 18:37